Clinical Study of Patients Treated With PuraBond Haemostatic Agent During Abdominal Aorta Open Repair

Inclusion Criteria:

• Patients with ≥ 18 years of age, presenting with an abdominal aortic aneurysm (pararenal, juxtarenal, infrarenal, aorto-iliac mono/bilateral)

• Use of the Purabond hemostatic agent in patients who, in the opinion of thePhysician, don't have a satisfactory surgical haemostasis

• Patients ≥ 18 years of age with steno-occlusive abdominal aortic or iliac disease

• Patients that will treated by open repair , encompassing elective, urgent andemergency presentation, hospitalized and enrolled in Vascular Surgery Unit, SanRaffaele Hospital (Milan, Italy)

• Patients able to sign specific informed consent for the study

Exclusion Criteria:

• Patients whom exhibited preoperative derangements in haematological and coagulationprofiles, and baseline derangements in liver function

• Patients with abdominal aortic and/or iliac arteries disease candidate forendovascular treatment

• Pregnant, breastfeeding, or planning on becoming pregnant within 24 months

• Systemic infection (for example: sepsis)

• Impossibility or refusal to give informed consent